Introduction
Over the last two decades, the popularity of amateur marathons has risen dramatically. nearly 500,000 individuals crossed the finish line of a marathon in 2012 (lamppa 2013). long-distance running is known to provide excellent health benefits and is associated with lower disability and increased life expectancy (chakravarty et al. 2008; Sarna et al. 1993) . However, there is some concern that marathon running may be dangerous to the heart. For example, sudden cardiac arrest (ScA) represents the leading cause of death during a marathon (Webner et al. 2012) . At least 40 people (1.01 per 100,000) suffered a ScA during a marathon in the last 10 years with a mortality rate of 0.63 per 100,000 (Kim et al. 2012) . While ScA during a marathon remains rare, the reported incidence of ScA in marathoners likely underestimates the true incidence as it was tabulated from media, Internet searches, and surveys.
ScA occurs more frequently during the last four (Webner et al. 2012 ) to 6.2 miles (Kim et al. 2012 ) of a marathon. It remains unclear whether cardiac instability increases towards the end of a marathon because the cardiovascular response throughout the marathon remains unknown and understudied. the present study characterized electrocardiogram (Ecg) changes in individuals as they completed a marathon.
Methods

Subjects and protocol
Written informed consent was obtained from all subjects and the Institutional review Board of the University of Pittsburgh approved all activities. ten participants were screened at each of three events: the 2012 Pittsburgh marathon, the 2013 galveston marathon, and the 2013 Seabrook lucky trail marathon. All participants in each marathon were invited to participate using flyers and informational emails. Subjects were selected to participate in the study based on their ability to wear the Holter monitor throughout the marathon, and their willingness to have their blood drawn before and after the race. Subjects were selected on a first-come, first-serve basis. the number of subjects in each race was limited by the number of Holter monitors available. An effort was made to recruit subjects of both sexes and of a variety of ages and running abilities to most accurately reflect the general population.
In the 1-to 3-h period prior to the start of a marathon, five-lead Holter monitors (nasiff, central Square, new York) were secured to subjects using tape, benzoin, and often compression shirts. Each Holter monitor collected three channels of data. For channel 1, the negative lead was applied to the center of the manubrium at the top of the sternum and the positive lead was applied to the left midclavicular line at the level of the 6th rib in V3 position. For channel 2, the negative lead was applied at the center of the manubrium at the top of the sternum and the positive lead was applied to the left anterior axillary line at the level of the 6th rib in V5 position. channel 3 was generated using a negative lead placed 1 inch to the right of the xiphoid process on the rib, just below V1 position at the bottom of the rib cage. the positive lead was placed at the left anterior axillary line at the level of the 6th rib in V5 position.
For each subject, the channel with the best quality of data and least amount of noise or interference was selected for further analysis. channel 1 was selected for analysis in 13 subjects. channel 2 was selected for 7 subjects and channel 3 was selected for 1 subject.
Electrocardiographic (Ecg) data were recorded at a sampling rate of 256 Hz before, during, and after the marathon. All data from Holter monitors were recorded directly onto an external data card. After the data were imported using cardiocard software (nasiff, central Square, new York), they were smoothed using a 5-point moving average and detrended across the entire recording and again over each QrSt complex using customized software (MAtlAB, Mathworks, natick, MA). All data were visually inspected to confirm adequate quality for analysis and to ensure that premature ventricular contractions (PVc) were excluded from analysis. Each heartbeat was defined as the peak of each r-wave.
Fourteen subjects (A in table 1) also wore gt3X+accelerometers (Actilife, Pensacola, Florida) which monitored their activity continuously at 100 Hz throughout the marathon. Before and after the marathon, 5-10 ml of blood was obtained from each subject to acquire basic metabolic profiles (BMP), creatine kinase (cK) levels, and troponin levels. Before the marathon, the subjects' body fat was estimated using skinfold calipers (lange, Ann Arbor, MI) applied at the chest, abdomen, and thigh for men and triceps, supra-iliac area, and thigh for women. Measurements were taken three times at each site. the average skinfold thickness at each site was used to estimate body fat. Definitions this study focused on specific measures of cardiac activity throughout a marathon. the primary measures of cardiac activity included: heart rate (Hr), HrV, t-wave amplitude, t-wave amplitude variability, and t-wave alternans (tWA). Heart rate variability was calculated as the root mean squared of the difference between subsequent r-r intervals (rMSSD), one measure of HrV (task Force 1996). t-wave amplitude was defined as the height of the t-wave at its maximum point (mV) normalized by the magnitude of the corresponding r-wave (mV), to control for variations in total signal amplitude. t-wave amplitude variability was defined as the standard deviation of the normalized t-wave amplitude. tWA, one form of t-wave variability, was defined as the average difference in normalized maximal amplitude between consecutive t-waves (nearing and Verrier 2002a). t-wave amplitude, t-wave amplitude variability, and tWA were expressed in arbitrary units as they were normalized by the corresponding r-wave. Hr, HrV, t-wave amplitude, t-wave amplitude variability, and tWA were all calculated using customized software (MAtlAB, Mathworks, natick, MA).
Holter analyses: elapsed time analysis and proportion of race analysis Hr, HrV, t-wave amplitude, t-wave amplitude variability, and tWA changes during the marathon were quantified using two separate analyses, termed an "elapsed time" analysis and a "proportion of race" analysis. Both the elapsed time and proportion of race analyses evaluated Hr, HrV, tWA, and t-wave variability throughout the marathon; however, the elapsed time analysis examined changes in cardiac activity as a function of the total duration of exercise, while the proportion of race analysis determined changes in cardiac activity relative to the proportion of the marathon completed.
In the elapsed time analysis, non-overlapping 30-min bins of data for each subject were normalized by the first 30 min of exercising data for the same subject to account for variability in measures of cardiac activity between individuals (Martinmaki et al. 2006) . these normalized values were analyzed using linear regression to evaluate how cardiac activity changed throughout the marathon in relation to total duration of exercise.
Prior studies report that the incidence of cardiac arrest increases towards the end of a marathon, irrespective of finishing time (Kim et al. 2012; Webner et al. 2012) . It was therefore important to determine how cardiac activity changed as a function of the proportion of the marathon completed in addition to the total duration of exercise. the proportion of race analysis was implemented such that cardiac activity across all runners at equivalent points in the marathon could be compared, irrespective of each runner's pace. this method divided each subject's continuous Ecg data into four equal proportions of time such that each proportion represented one-quarter of the total race time for each subject. Using this approach, each proportion included data from 19 subjects and was compared using Friedman tests with Dunn's post test comparisons to control for inter-subject variability because the data were not normally distributed. In order for a change to be considered a marathon-related effect on cardiac activity, the p value from both the elapsed time and proportion of race analysis was required to be <0.05.
correlations between marathon-related changes in each measure of cardiac activity with race time were performed using Spearman correlation. For these analyses, the degree of change in each measure of cardiac activity was defined as the percent change in each measure between the last and first 30-min bin in the elapsed time analysis.
Pre-marathon recordings included 3 min of data recorded 17 ± 11 min (mean ± SD) before the start of the marathon, while post-marathon recordings included 3 min of data that began 3 min after completion of the marathon. Wilcoxon matched pairs tests were used to compare each measure of cardiac activity pre-versus post-marathon. Means ± SD were reported unless otherwise specified. All statistical analyses were performed using Prism (graphpad, la Jolla, cA).
Activity analysis
Acceleration data from 13 subjects were imported into Actilife software directly from each gt3X+device (Actilife, Pensacola, Florida). these data were used to Table 1 Summary of all subjects Each subject is listed in the temporal order in which they were recruited Subjects 1-10 ran the 2012 Pittsburgh marathon, subjects 11-18 ran the 2013 galveston marathon, and subjects 19-28 ran the 2013 Seabrook lucky trail marathon Subj # indicates each subject's number, * denotes a subject with premarathon, marathon, and post-marathon data, ** denotes one of the two additional subjects with pre-marathon data and partial marathon data, A denotes subjects who wore actigraphs and race time indicates the number of seconds each subject took to complete the marathon quantify changes in acceleration throughout the marathon in both the elapsed time and proportion of race analysis using Prism (graphpad, la Jolla, cA).
Blood analyses
Blood was drawn from a subset of subjects between 1 and 21 days prior to the marathon and again immediately after the marathon. Whole-blood BMP (i-StAt, Abbott, Princeton, new Jersey), cK (EcPK-100, BioAssay Systems, Hayward, cA) and troponin-I levels (BQ015c kits, gentaur, San Jose, cA, respectively) were compared before and after the marathon using Wilcoxon matched pairs tests (Prism, graphpad, la Jolla, cA).
Results
twenty-eight subjects provided consent for the study (table 1) . One subject failed to start the marathon. Data from six other subjects were excluded due to noise during the recording, data card malfunction, or Holter malfunction. Data from the remaining 21 individuals (* in table 1) were analyzed before and during the marathon. In 2 of these 21 subjects (** in table 1), data collection was interrupted towards the end of the marathon due to mechanical failure. Partial data (61 % and 41 % of their total marathon running time, respectively) from these two subjects were used in the elapsed time analysis alone. Ecg data from the remaining 19 subjects were used in both the elapsed time and proportion of race analyses. After removing noise, 84-100 % of data from each subject was used for analysis. nine subjects completed the 2012 Pittsburgh marathon, six completed the 2013 galveston marathon, and four completed the 2013 Seabrook lucky trail marathon. the two subjects with partial marathon data completed the 2013 Seabrook marathon. Sample data from one subject are depicted in Fig. 1 , demonstrating Ecg recordings that were acquired before, during, and after the marathon.
Subjects' performance in the race the 19 subjects comprised a group of 14 men and 5 women aged 39 ± 16 (mean ± SD) who completed a marathon in 4:32:16 ± 1:23:35. the average body fat of this cohort was 16 ± 7 % and BMI was 23 ± 6. When including the two additional subjects with partial marathon data, the group was comprised of 15 men and 6 women aged 42 ± 13 who completed a marathon in 4:44:06 ± 54:06. the average body fat was 17 ± 6 % and BMI was 24 ± 3. Due to limited supply, only 13 subjects wore actigraphs (A in table 1). Averaged across all runners, acceleration decreased during the marathon by both the elapsed time analysis (p = 0.0007, slope = −0.06) and the proportion of race method (p = 0.0035).
Heart rate did not change throughout the marathon, but was elevated after the marathon Averaged across all subjects, Hr decreased with time throughout the marathon (Fig. 2a) by the elapsed time analysis (p = 0.04, slope = −0.02; Fig. 2b ), but not by the proportion of race analysis (p = 0.07; Fig. 2c ). therefore, there was no robust change in Hr. When examining individual subjects, Hr decreased during the marathon in 10 subjects and increased during the marathon in 11 subjects. A positive correlation was evident between marathonrelated changes in Hr and race time (p = 0.02, R = −0.5), such that faster runners tended to exhibit an increase in Hr as the marathon progressed. three min after completion of the marathon, Hr was elevated relative to Hr just prior to the marathon (p = 0.0001; Fig. 2d ).
Heart rate variability increased during the marathon, but was suppressed after the marathon Averaged across all subjects, HrV increased during the marathon (Fig. 3a) by the elapsed time analysis (p < 0.0001, slope = 0.34; Fig. 3b ) and the proportion of race analysis (p = 0.046; Fig. 3c ). twelve subjects exhibited an increase in HrV during the marathon, while nine subjects exhibited a decrease in HrV. there was no relationship between marathon-related changes in HrV and total race time. three min after completion of the marathon, HrV was decreased relative to HrV just prior to the marathon (p = 0.001; Fig. 3d ).
t-wave amplitude variability increased during the marathon, but normalized after the marathon
Averaged across all subjects, t-wave amplitude (Fig. 4b) increased by the elapsed time analysis (p < 0.0001, slope = 0.09; Fig. 4d ) in 17 of 21 subjects, but did not change by the proportion of race analysis (Fig. 4f) . there was no relationship between marathon-related changes in t-wave amplitude and race time. three min after completion of the marathon, t-wave amplitude was no different from pre-marathon values (p = 0.35; Fig. 4h ). In contrast, t-wave amplitude variability increased dramatically throughout the marathon (Fig. 4a, c) by both the elapsed time analysis (p < 0.0001, slope = 0.32, Fig. 4e ) and the proportion of race analysis (p = 0.0025; Fig. 4g ). t-wave amplitude variability increased during the marathon in 18 of 21 subjects. there was no relationship between marathon-related changes in t-wave amplitude variability and race time. t-wave amplitude variability was similar both before the marathon and 3 min after the marathon (p = 0.08; Fig. 4i ).
Evidence of t-wave alternans increased during the marathon, but normalized after the marathon Increases in t-wave amplitude variability during the marathon included complex oscillations and tWA (Figs. 1, 5a , b). tWA increased markedly throughout the marathon by both the elapsed time (p < 0.0001, slope = 0.33; Fig. 5c ) and the proportion of race analysis (p = 0.0002; see Fig. 5d ). tWA increased in 18 of 21 subjects. there was no relationship between the magnitude of change in tWA and race time. tWA was similar both before the marathon and 3 min after the marathon (p = 0.07; Fig. 5e ).
Marathon-related changes in BMP, cK, and troponin Sodium (140.1 ± 2.14 mEq/l pre; 139.7 ± 3.3 post), potassium (4.2 ± 0.4 mEq/l pre; 4.3 ± 0.4 post), calcium (1.2 ± 0.06 mg/dl pre and post), hematocrit (43.4 ± 3.8 % pre; 42.7 ± 5.4 post), and hemoglobin (14.8 ± 1.3 gm/dl pre; 14.5 ± 1.8 post) did not differ pre-versus post-marathon. no subject's sodium was <132 or >145 and no subject's potassium was <3.5 or >5 either before or after the marathon. troponin-I was undetectable pre-and post-marathon. creatinine (cr) increased from 0.96 ± 0.2 mg/dl before the marathon to 1.5 ± 0.4 after the marathon (p < 0.0001).
Blood urea nitrogen (BUn) also increased from 16.8 ± 5.4 mg/dl before the marathon to 20.8 ± 5.5 after the marathon (p = 0.005). the post-marathon BUn:cr ratio was ≤ 10 in two subjects with cr levels of 1.7 mg/dl and 2.6. cK was increased from 30 ± 36 U/l before the marathon to 110 ± 70 after the marathon (p < 0.0001). One subject's post-marathon cK value reached 281. Post-marathon cK levels were not correlated with marathon-related changes in Hr, HrV, t-wave amplitude, t-wave amplitude variability, or tWA.
Discussion
this is the first study to examine continuous Ecg data during a marathon. nearly all prior studies examining the cardiac effects of marathon completion evaluated subjects pre-and post-marathon. We found that HrV, t-wave amplitude variability, and tWA increased throughout a marathon. relative to pre-marathon values, post-marathon Hr increased and HrV decreased, while t-wave amplitude variability and tWA remained unchanged. there was no evidence of acute myocyte damage following the marathon.
Marathon-related changes in t-wave amplitude variability and t-wave alternans t-wave amplitude variability and tWA increased throughout the marathon in nearly all participants (examples in Figs. 1a, 4a, and 5a) . tWA is thought to be caused by a Fig. 3 changes in HrV using rMSSD (seconds) before, during, and after the marathon. a HrV before, during, and after the marathon is plotted continuously. b the change in HrV over time during the marathon in 30-min non-overlapping intervals. c the change in HrV during each proportion of the marathon. d HrV pre-versus post-marathon. Unless otherwise stated, the conformities of Fig. 3 are identical to that of Fig. 2 spatial dispersion of repolarization that can occur following ischemia to a focal region of the heart (chinushi et al. 1998) or by temporal dispersion of repolarization that occurs with rapid alterations of calcium and ion cycling at higher Hr (Kavesh et al. 1998; Pastore et al. 1999; Schwartz and Malliani 1975) . Increasing tWA throughout the marathon was Fig. 4 changes in t- waves before, during, and after the marathon. a Examples of Ecg tracings from two subjects showing variability in t-waves during the marathon. b t-wave amplitude before, during, and after the marathon is plotted continuously in arbitrary units. c t-wave amplitude variability before, during, and after the marathon is plotted continuously in arbitrary units. d the change in t-wave amplitude over time during the marathon in 30-min non-overlapping intervals. e the change in t-wave amplitude variability over time during the marathon in 30-min non-overlapping intervals. f the change in t-wave amplitude during each proportion of the marathon. g the change in t-wave amplitude variability during each proportion of the marathon. h t-wave amplitude pre-versus post-marathon in arbitrary units. i t-wave amplitude variability pre-versus post-marathon in arbitrary units. Unless otherwise stated, all conformities of Fig. 4 are identical to that of Fig. 2 not related to changes in Hr, as Hr remained unchanged throughout the marathon. Furthermore, post-marathon Hr was elevated relative to pre-marathon Hr, while tWA returned to baseline. Increasing metabolic demands throughout the marathon could increase temporal dispersion of repolarization by altering ion cycling (Verrier and Malik 2013) .
the clinical implications of increasing tWA throughout a marathon remain unclear. Abnormalities in repolarization and calcium cycling are linked to arrhythmogenesis (Verrier and Malik 2013), and tWA is associated with an increased risk of ventricular arrhythmias (Adam et al. 1984; raeder et al. 1992) . Spatial and temporal dispersions of repolarization are thought to cause arrhythmias by preventing depolarization in a specific group of myocytes or by inducing conduction block and fibrillation (narayan 2006) . In response to ischemia, tWA evolves into higher order oscillations in t-wave amplitude that can culminate in ventricular fibrillation (nearing and Verrier 2002b), visibly similar to the oscillatory nature of t-wave amplitude variability observed in this study (Fig. 1a) .
Exercise stress test-induced tWA reportedly predicts the inducibility of sustained ventricular tachycardia or ventricular fibrillation (Estes et al. 1997) and is associated with cardiac mortality and sudden cardiac death . A greater magnitude of tWA is also associated with a higher risk of developing ventricular tachycardia (Kavesh et al. 1998 ) and ischemia-induced ventricular fibrillation, independent of Hr (nearing et al. 1994 Hr (nearing et al. , 1996 nieminen et al. 2011) . thus, it would seem plausible that increasing tWA as a marathon progresses might heighten the risk of arrhythmias. However, nearly all subjects in this study exhibited marathon-related increases in tWA without developing an arrhythmia or cardiac event. Furthermore, only ~14 % of ScAs during a marathon are thought to be attributable to arrhythmias (Kim et al. 2012) . thus, increased tWA as a marathon progresses most likely represents a physiologic response to prolonged exercise. However, it is difficult to ignore the previously established association between tWA and arrhythmias. As subjects in this study were not screened for pre-existing cardiac pathology, future studies would be necessary to delineate the Marathon-related changes in Hr and HrV the finding that HrV increased throughout the marathon was surprising, as previous work has shown that HrV is suppressed during exercise and that HrV decreases with increasing oxygen consumption during exercise (Perini et al. 2000) . Increasing HrV is unlikely attributable to changes in Hr, because Hr remained unchanged, or to an increasing frequency of PVcs, because PVcs were excluded from analysis. Atrial arrhythmias could increase HrV as the marathon progresses; however, no arrhythmias were observed in any of the subjects. Vagally-mediated HrV diminishes when an individual is exercising at greater than 50-60 % of maximal performance (tulppo et al. 1996 Yamamoto et al. 1991) . throughout the marathon, a progressive decrease in vagally-mediated HrV in conjunction with an increase in sympathetic drive may increase HrV throughout the marathon.
relative to the beginning of the marathon, HrV decreased after the marathon while Hr increased. An elevation in nocturnal resting Hr and a suppression of nocturnal resting HrV have been previously reported after completion of a marathon, and are thought to reflect parasympathetic withdrawal with delayed sympathetic de-activation (Hynynen et al. 2010) . the imbalance generated by suppressed vagal activity and increased sympathetic activity (Malik and camm 1993) has the potential to induce electrical instability, generating a pro-arrhythmic state. Indeed, low resting HrV represents a strong and independent predictor of mortality and arrhythmic complications following acute myocardial infarction (Kleiger et al. 1987) and is thought to reflect cardiac instability (tsuji et al. 1996) . Suppressed HrV after a marathon could suggest increased cardiac instability after a marathon. Indeed, endurance athletes have a greater incidence of ventricular arrhythmias (Abdulla and nielsen 2009; Heidbuchel et al. 2012) than the general population.
Marathon-related changes in blood markers of cardiac damage
In an effort to identify whether marathon-related changes in cardiac activity might be associated with acute cardiac stress or damage, we measured marathon-related changes in troponin and cK. cardiac troponin did not increase after the marathon. this finding is consistent with some studies (lucia et al. 1999; Smith et al. 2004 ) while others report that cardiac troponin levels are elevated to ≥0.03 ng/ml in ~40 % of people immediately post-marathon (Fortescue et al. 2007; neilan et al. 2006) . total cK levels increased after the marathon. In previous studies, cK and cK-MB, were found to increase 4-8 h after a marathon (lucia et al. 1999 ) and 24 h post-marathon (Siegel et al. 1997 ). this finding is thought to reflect primarily skeletal muscle damage, as individuals with elevated post-marathon cK and cK-MB levels were asymptomatic and free of cardiac events 1 year later (Siegel et al. 1997) with no evidence of myocardial necrosis on cardiac MrI (Mousavi et al. 2009 ). Importantly, there were no correlations between post-marathon cK and marathon-related changes in cardiac activity.
limitations and potential confounds
Increasing variability in t-wave amplitude during the marathon might be attributable to increasingly poor contact of the electrodes to the body or variations in respiratory cycle. the extensive taping methods and compression shirts employed in this study maximally optimized the quality of Ecg signal obtained. Any variability in electrode contact would affect the amplitude of both the r-wave and t-wave. therefore, the t-wave amplitudes were normalized by corresponding r-wave amplitudes. Of note, the post-marathon recordings were performed without altering the electrode contacts, yet t-wave amplitude variability returned to pre-marathon values within 3 min following the marathon. Above all, alternations in electrode contact would be unlikely to explain an increase in the difference between consecutive heart beats' t-wave amplitudes, measured as tWA.
While great efforts were made to ensure that electrode contacts remained stable and data were visually inspected to ensure that the quality of recordings remained uniform throughout the marathon, exercise-related changes in electrode contacts may represent one minor source of artifact. the respiratory cycle could also influence the changes in HrV and t-wave amplitude variability that we observed.
Other limitations of this study included the small sample size and heterogeneity of the population. We did not attempt to exclude any individual based on age or gender to obtain a dataset most representative of typical marathon participants. Indeed, the average finish time of 4:32:16 ± 1:23:35 was similar to the average finish time of all marathon runners: 4:28:48 (lamppa 2013). roughly, 10 % of our subjects qualified for the Boston Marathon, which is similar to the 10.4 % of all marathoners who qualify in a given year (Hamilton 2013). While this cohort was representative of the general population of marathon participants, there were too few subjects to divide our data into further subgroups based on age, gender, or training duration and type. Future studies would be necessary to determine whether individual measures of cardiac activity would be differentially influenced by age, gender, training, or pre-existing cardiac disease.
Conclusions
Heart rate variability, t-wave amplitude variability, and tWA increased throughout a marathon. Increasing tWA as a marathon progresses likely represents a physiologic process as no arrhythmias or cardiac events were observed. the implications of these changes in different clinical populations remain an important topic of future study in an effort to improve the safety of endurance sport.
